Rogelio Escobedo-Gomez
Mexico City, DIF 07320, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Antiamoeba and Antitrypanosoma Activity of the Mexican Plectranthus amboinicus Essential Oil.
Journal: Pathogens (Basel, Switzerland)
Published: July 01, 2026
Purine derivatives as potential agents against Chagas disease: Ex vivo, in vitro, in silico evaluation, and identification of targets in Trypanosoma cruzi.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 20, 2026
Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Trypanosoma cruzi Agents: An In Silico and In Vitro Approach.
Journal: Molecules (Basel, Switzerland)
Published: January 31, 2026
An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2026
Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity.
Journal: Diseases (Basel, Switzerland)
Published: January 15, 2026
Organometallic gold(III) (C^S)-cyclometallated complexes as candidates to new drugs against chagas disease.
Journal: Bioorganic & medicinal chemistry letters
Published: November 10, 2025
Virtual Screening of FDA-Approved Drugs on Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) to Obtain New Trypanocidal Agents.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: May 07, 2025
Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for Trypanosoma cruzi Infection.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 09, 2024
Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents.
Journal: Molecules (Basel, Switzerland)
Published: July 01, 2024
Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening.
Journal: Archives of medical research
Published: August 15, 2023
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors.
Journal: International journal of molecular sciences
Published: August 30, 2022
Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents.
Journal: International journal of molecular sciences
Published: June 30, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026